- Home
- OLP vs ARCT Comparison
OLP vs ARCT Comparison
Compare OLP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLP | ARCT |
|---|---|---|
| Founded | 1982 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.4M | 189.9M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OLP | ARCT |
|---|---|---|
| Price | $22.27 | $6.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $27.50 | ★ $27.70 |
| AVG Volume (30 Days) | 65.1K | ★ 452.6K |
| Earning Date | 03-05-2026 | 03-03-2026 |
| Dividend Yield | ★ 7.98% | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $82,740,000.00 | $82,031,000.00 |
| Revenue This Year | $7.87 | N/A |
| Revenue Next Year | $4.40 | N/A |
| P/E Ratio | $19.63 | ★ N/A |
| Revenue Growth | ★ 1.02 | N/A |
| 52 Week Low | $19.62 | $5.85 |
| 52 Week High | $26.86 | $24.14 |
Technical Indicators
Market Signals| Indicator | OLP | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 38.70 | 38.14 |
| Support Level | $21.94 | $5.93 |
| Resistance Level | $22.30 | $7.88 |
| Average True Range (ATR) | 0.63 | 0.42 |
| MACD | -0.18 | -0.12 |
| Stochastic Oscillator | 6.54 | 10.91 |
Price Performance
Historical ComparisonAbout OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.